Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antinociception and neuroprotection of the peptidic G protein-coupled estrogen receptor inverse agonist PLMI in the murine model of paclitaxel-induced peripheral neuropathy.

British journal of pharmacology·2026
Same author

fMRI data acquisition and analysis for task-free, anesthetized rats.

Nature protocols·2025
Same author

Deciphering the influence of evolutionary legacy and functional constraints on the patella: an example in modern rhinoceroses amongst perissodactyls.

PeerJ·2024
Same author

Mobile Health App and Web Platform (eDOL) for Medical Follow-Up of Patients With Chronic Pain: Cohort Study Involving the French eDOL National Cohort After 1 Year.

JMIR mHealth and uHealth·2024
Same author

The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024
Same author

Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER.

Frontiers in pharmacology·2024

Related Experiment Video

Updated: May 17, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

[Paracetamol: a promising ancestor].

Christophe Mallet, David A Barrière, Alain Eschalier

    Therapie
    |November 1, 2012
    PubMed
    Summary

    Paracetamol, a widely used pain reliever, has complex mechanisms of action involving multiple body systems. Recent research reveals paracetamol acts as a pro-drug, requiring bio-transformation for its analgesic effects.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Toxicology

    Background:

    • Paracetamol is a globally prevalent analgesic and antipyretic medication.
    • Despite its widespread use, the precise mechanisms underlying paracetamol's therapeutic and toxic effects remain incompletely understood.
    • Existing research highlights the involvement of serotonergic and prostaglandin systems in paracetamol's action.

    Purpose of the Study:

    • To elucidate the molecular targets and mechanisms responsible for paracetamol's analgesic effects.
    • To identify potential targets for developing safer and more effective analgesics.
    • To explore the roles of newly implicated endogenous systems in paracetamol's pharmacology.

    Main Methods:

    • Review of existing literature on paracetamol's pharmacology and toxicology.

    Related Experiment Videos

    Last Updated: May 17, 2026

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
    05:37

    Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

    Published on: May 31, 2018

  • Analysis of studies investigating the involvement of various endogenous systems, including serotonergic, prostaglandin, cannabinoid, and vanilloid pathways.
  • Examination of recent research proposing a pro-drug model for paracetamol's activation.
  • Main Results:

    • Paracetamol's analgesic action involves complex interactions with multiple endogenous systems.
    • The serotonergic, prostaglandin, cannabinoid, and vanilloid systems are implicated in its effects.
    • Emerging evidence suggests paracetamol functions as a pro-drug, necessitating bio-transformation to exert its analgesic properties.

    Conclusions:

    • Paracetamol's mechanism of action is multifaceted, involving several interconnected biological systems.
    • Understanding paracetamol as a pro-drug offers new perspectives on its efficacy and potential for developing improved analgesics.
    • Further research into these pathways may unlock novel therapeutic strategies for pain management.